Zevra Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
ZVRA on Nasdaq
Industry
Pharmaceutical Preparations
Location
1180 Celebration Boulevard, Suite 103, Celebration, FL

Insiders trading volume in the past year

Zevra Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Samuel J. Braun 10%+ Owner $15.6M May 13, 2021
Neil F. McFarlane President and CEO, Director $2.43M -$727K -23% Feb 13, 2025
Rahsaan Thompson Chief Legal & Compliance, Secretary $1.26M Jan 30, 2025
Travis C. Mickle President & CEO, Director $852K May 25, 2022
R. LaDuane Clifton CFO & Treasurer $673K -$72.9K -9.78% Feb 13, 2025
Joshua Schafer CCO & EVP, Bus. Development $501K -$82.5K -14.1% Feb 13, 2025
Sven Guenther Chief Scientific Officer $392K Jan 31, 2024
Christal M. M. Mickle Chief Development Officer $382K Jan 31, 2024
John B. Bode Director $318K +$138K +76.7% Mar 19, 2025
Adrian W. Quartel Chief Medical Officer $294K Jan 30, 2025
Timothy J. Sangiovanni SVP, Finance & Corp Controller $279K -$23.6K -7.8% Feb 13, 2025
Richard W. Pascoe Chief Executive Officer, Director $149K Mar 9, 2023
Thomas Anderson Director $136K +$68.1K +100% Jul 16, 2024
Matthew R. Plooster Director $92.1K Apr 25, 2023
David S. Tierney Director $53.7K Mar 9, 2023
Corey M. Watton Director $14.1K +$6.31K +80.9% Mar 28, 2025
Christopher Posner Director Nov 28, 2022
Joseph Saluri Director Apr 25, 2023
Wendy L. Dixon Director May 13, 2024
Tamara A. Favorito Director May 13, 2024
Alvin Shih Director May 13, 2024
Douglas Calder Director May 13, 2024

Recent Insider Transactions by Companies or Individuals for Zevra Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.